THE FREQUENCY OF ANTIPSYCHOTIC POLYPHARMACY IN "HIGH-UTILIZING'' PATIENTS WITH SCHIZOPHRENIA IN GERMANY

被引:0
|
作者
Janssen, Birgit [1 ]
Schmidt-Kraepelin, C. [1 ]
Puschner, B. [2 ]
Gaebel, Wolfgang [1 ]
机构
[1] Heinrich Heine Univ Duesseldorf, LVR Klinikum Duesseldorf, Dusseldorf, Germany
[2] Univ Ulm, Gunzburg, Germany
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:306 / 307
页数:2
相关论文
共 50 条
  • [1] Antipsychotic polypharmacy in patients with schizophrenia
    Kim, Chan-Hyung
    [J]. ASIA-PACIFIC PSYCHIATRY, 2012, 4 : 19 - 19
  • [2] Antipsychotic Polypharmacy in High-Utilising Patients with Schizophrenia
    Schmidt-Kraepelin, Christian
    Puschner, Bernd
    Loos, Sabine
    Janssen, Birgit
    [J]. PSYCHIATRISCHE PRAXIS, 2013, 40 (07) : 380 - 384
  • [3] Antipsychotic Polypharmacy in the Treatment of Patients with Schizophrenia in Nine Psychiatric Hospitals of the Landschaftsverband Rheinland, Germany
    Schmidt-Kraepelin, Christian
    Meisenzahl-Lechner, Eva
    Kujovic, Milenko
    Cordes, Joachim
    Engelke, Christina
    Riesbeck, Mathias
    Zielasek, Jurgen
    Engemann, Sandra
    Vrinssen, Jurgem
    Lehmann, Isabell
    Tonnesen-Schlack, Anita
    Banger, Markus
    Grummer, Martine
    Scherbaum, Norbert
    Muysers, Jutta
    Rinckens, Stephan
    Marggraf, Ralph
    Gouzoulis-Mayfrank, Euphrosyne
    [J]. PSYCHIATRISCHE PRAXIS, 2021, 48 (05) : 250 - 257
  • [4] Antipsychotic treatment in elderly patients on polypharmacy with schizophrenia
    Stuhec, Matej
    [J]. CURRENT OPINION IN PSYCHIATRY, 2022, 35 (05) : 332 - 337
  • [5] Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
    Joe, Soohyun
    Ahn, Joonho
    Choi, Youngmin
    Lee, JungSun
    Park, Jangho
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 192 - 193
  • [6] Antipsychotic polypharmacy in the treatment of schizophrenia
    Correll, CU
    Kane, JM
    O'Shea, D
    Razi, K
    Malhotra, AK
    [J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 37 - 37
  • [7] Antipsychotic Polypharmacy in Patients With Schizophrenia in a Brief Hospitalization Unit
    Lerma-Carrillo, Ivan
    de Pablo Bruhlmann, Silvia
    Leonor del Pozo, Marta
    Pascual-Pinazo, Fernando
    Molina, Juan D.
    Baca-Garcia, Enrique
    [J]. CLINICAL NEUROPHARMACOLOGY, 2008, 31 (06) : 319 - 332
  • [8] Antipsychotic Polypharmacy in Schizophrenia: Why Not?
    Guinart, Daniel
    Correll, Christoph U.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2020, 81 (03)
  • [9] A Randomized Trial of Treatments for High-Utilizing Somatizing Patients
    Arthur J. Barsky
    David K. Ahern
    Mark R. Bauer
    Nyryan Nolido
    E. John Orav
    [J]. Journal of General Internal Medicine, 2013, 28 : 1396 - 1404
  • [10] High doses of antipsychotic polypharmacy are related to an increase in serum levels of pentosidine in patients with schizophrenia
    Sannohe, Takahiro
    Ohnuma, Tohru
    Takeuchi, Masayoshi
    Tani, Eriko
    Miki, Yasue
    Takeda, Mayu
    Katsuta, Narimasa
    Takebayashi, Yuto
    Nakamura, Toru
    Nishimon, Shohei
    Kimoto, Ayako
    Higashiyama, Ryoko
    Shibata, Nobuto
    Gohda, Tomohito
    Suzuki, Yusuke
    Yamagishi, Sho-ichi
    Tomino, Yasuhiko
    Arai, Heii
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 76 : 42 - 48